Xeris Biopharma Holdings, Inc. (XERS)
6.38
+0.15
(+2.41%)
USD |
NASDAQ |
May 21, 16:00
6.40
+0.02
(+0.31%)
After-Hours: 19:59
Xeris Biopharma Holdings Market Cap : 1.101B for May 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zoetis, Inc. | 33.57B |
| Harrow, Inc. | 1.229B |
| Corcept Therapeutics, Inc. | 6.408B |
| Assertio Holdings, Inc. | 149.96M |
| Johnson & Johnson | 557.82B |
Market Cap Related Metrics
| PE Ratio | 97.40 |
| PS Ratio | 3.520 |
| Price to Book Value | 84.66 |
| Price to Free Cash Flow | 23.32 |
| Price | 6.38 |
| Earnings Yield | 1.03% |
| Operating PE Ratio | 30.87 |
| Normalized PE Ratio | 97.40 |